Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The risk of nephrotic range proteinuria and kidney failure in primary laminopathies is genotype specific
Sebastian Sewerin, Charlotte Aurnhammer, Mohamed Hamed, Gwladys Revêchon, Ria Schönauer, Christin Findeisen, Konstanze Miehle, Šárka Tesařo vá, Theodoros Georgomanolis, Carsten Bergmann, Constantin Wolff, Marek Kollár, Baris Akinci, David Araújo-Vilar, Giovanni Ceccarini, Éva Csajbók, Alessandra Gambineri, Martin Heni, Thomas Scherer, Iztok Štotl, Ekaterina Sorkina, Marie-Christine Vantyghem, Elena Vorona, Martin Wabitsch, Julia von Schnurbein, Camille Vatier, Joëlle Roume, Yves Reznik, Maria Eriksson, Wolfram Antonin, Corinne Vigouroux, Jan Halbritter
Sebastian Sewerin, Charlotte Aurnhammer, Mohamed Hamed, Gwladys Revêchon, Ria Schönauer, Christin Findeisen, Konstanze Miehle, Šárka Tesařo vá, Theodoros Georgomanolis, Carsten Bergmann, Constantin Wolff, Marek Kollár, Baris Akinci, David Araújo-Vilar, Giovanni Ceccarini, Éva Csajbók, Alessandra Gambineri, Martin Heni, Thomas Scherer, Iztok Štotl, Ekaterina Sorkina, Marie-Christine Vantyghem, Elena Vorona, Martin Wabitsch, Julia von Schnurbein, Camille Vatier, Joëlle Roume, Yves Reznik, Maria Eriksson, Wolfram Antonin, Corinne Vigouroux, Jan Halbritter
View: Text | PDF
Clinical Research and Public Health Genetics Nephrology

The risk of nephrotic range proteinuria and kidney failure in primary laminopathies is genotype specific

  • Text
  • PDF
Abstract

BACKGROUND Primary laminopathies are a heterogeneous group of rare diseases caused by nuclear lamina dysfunction due to pathogenic LMNA variants. However, despite their ubiquitous expression, LMNA variants have rarely been linked to chronic kidney disease (CKD). Here, we systematically investigate clinical implications and functional underpinnings of a distinct LMNA missense variant [lamin A/C p.(Arg349Trp)] that has sporadically been found in patients with a complex phenotype including lipodystrophy, proteinuria, and focal segmental glomerulosclerosis (FSGS).METHODS In clinical and functional terms, we compare lamin A/C Arg349Trp with missense changes at Arg482, the most common hotspot residue for type 2 familial partial lipodystrophy (FPLD2). In particular, we assess renal endpoints in corresponding patient cohorts and investigate disease-associated alterations in vitro.RESULTS In contrast to patients with FPLD2, individuals with lamin A/C Arg349Trp experience high-grade proteinuria and a rapid decline of glomerular filtration rate with kidney failure at a median age of 43 years. Mechanistically, we demonstrate that Arg349Trp associates with an abrogation of the structural interaction between lamin A/C and nucleoporin 155, nuclear pore complex aggregation, and an alteration of TGF-β1–dependent signaling.CONCLUSION While patients with Lamin A/C Arg482 missense changes are at very low risk for progressive CKD, patients harboring Arg349Trp show nephrotic range proteinuria and kidney failure in midlife. Hence, high-grade proteinuric kidney disease is genotype specific, and patients with the Arg349Trp substitution require early renoprotective intervention to potentially halt progression and prevent kidney failure.FUNDING German Research Foundation, project IDs 502928386, 508310822, 539950728, 445703531, 451693578, 471294925, 496611648, and 539950728; Else Kröner-Fresenius Foundation (2019_A96).

Authors

Sebastian Sewerin, Charlotte Aurnhammer, Mohamed Hamed, Gwladys Revêchon, Ria Schönauer, Christin Findeisen, Konstanze Miehle, Šárka Tesařo vá, Theodoros Georgomanolis, Carsten Bergmann, Constantin Wolff, Marek Kollár, Baris Akinci, David Araújo-Vilar, Giovanni Ceccarini, Éva Csajbók, Alessandra Gambineri, Martin Heni, Thomas Scherer, Iztok Štotl, Ekaterina Sorkina, Marie-Christine Vantyghem, Elena Vorona, Martin Wabitsch, Julia von Schnurbein, Camille Vatier, Joëlle Roume, Yves Reznik, Maria Eriksson, Wolfram Antonin, Corinne Vigouroux, Jan Halbritter

×

Figure 2

Lamin A/C Arg349Trp associates with high levels of proteinuria and kidney failure.

Options: View larger image (or click on image) Download as PowerPoint
Lamin A/C Arg349Trp associates with high levels of proteinuria and kidne...
(A) AlphaFold modeling of WT lamin A. (B) Proportions of patients harboring the indicated lamin A/C protein variants in the entire cohort of patients with primary laminopathies reported through the European Consortium of Lipodystrophies (ECLip) registry. (C) With a more than 10-fold difference, proteinuria (mg/24h) was significantly higher in lamin A/C Arg349Trp carriers (red; n = 23, mean 3186 mg/24h) as compared with patients harboring the Arg482Trp (dark blue; n = 63, mean 151.1 mg/24h) or the Arg482Gln (light blue; n = 9, mean 147.9 mg/24h) substitution (left; 1-way ANOVA with Bonferroni-corrected post hoc tests; mean + SD). Pearson correlation between proteinuria and age was not significant for any of the 3 patient cohorts (right). The y intercept, but not the slope, of the straight interpolation line for the lamin A/C Arg349Trp cohort differed significantly from that of the joint FPLD cohort (i.e., Arg482Trp or Arg482Gln carriers). The 95% CIs of interpolation lines are indicated by colored bands. For correlations and the interpolation comparison, P values were Bonferroni-corrected. Of note, for n = 26 individuals only “mg/g creatinine” was available. All groups were tested for the presence of outliers using Grubb’s test, yielding 1 data point in the Arg482Trp group that was excluded from analyses but displayed in the graphs. (D) In comparison with the joint cohort of patients harboring either lamin A/C Arg482Trp (dark blue) or Arg482Gln (light blue), the eGFR slope was significantly reduced for the cohort of lamin A/C Arg349Trp patients (red). (E) Kaplan-Meier analysis showing a significant reduction in kidney failure-free survival for patients harboring lamin A/C Arg349Trp (red; 31.6% kidney failure at a median age of 43) when compared with those with the Arg482Trp (dark blue; 1.3% kidney failure) or those with the Arg482Gln variant (light blue; 0.0% kidney failure). Log-rank tests with Bonferroni-correction. (F) Prevalence of diabetes in cohorts of patients harboring either lamin A/C Arg349Trp or Arg482Trp or Arg482Gln. (G and H) In comparing lamin A/C Arg349Trp harboring patients with those carrying the Arg482Trp or the Arg482Gln variant, multivariate Cox regression analyses showed that the LMNA genotype was a significant covariate for both nephrotic range proteinuria and kidney failure. Median with range. ns, not significant; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts